Watch list  ›  Fourier Intelligence

Fourier Intelligence傅利叶

Private Humanoid robots Private / pre-IPO
Status
Private / pre-IPO
Watch list category
PAI exposure
100%
Estimated
Funding stage
Series C+
$228M raised
HQ
Shanghai
Founded 2015

About

Leading Chinese humanoid robotics company that pivoted from rehabilitation robots to general-purpose humanoid robots. Founded in 2015 by Gu Jie (顾捷), a Shanghai Jiaotong University graduate with experience at FANUC and GM. Fourier's GR-1 (launched July 2023) was one of the first Chinese humanoid robots to achieve mass production delivery — 165cm tall, 55kg, 40 DOF. The GR-2 (September 2024) upgraded to 175cm, 63kg, 53 DOF with 12-DOF dexterous hands, single-arm 3kg payload, and 2-hour battery life. GR-2 introduced pure vision perception (BEV+Transformer+OCC with 6 RGB cameras). Also develops self-designed FSA (Force-controlled Series Actuator) joints. Rehabilitation robot business continues alongside humanoid development, with CE MDR Class II certified products deployed globally. In 2025, released open-source robot N1. Valued at ¥8 billion (~$1.1B) after E-round in January 2025, making it an official unicorn.

Shanghai, Shanghai · Founded 2015 · Company website

Why on the watch list

Humanoid and rehabilitation robotics pure-play.

Key Physical AI activities

  • GR-1 Humanoid RobotFirst-gen general-purpose bipedal humanoid. 165cm, 55kg, 40 DOF, 32 FSA joints, max torque 230Nm. First Chinese humanoid to achieve mass production delivery.
  • GR-2 Humanoid RobotSecond-gen humanoid. 175cm, 63kg, 53 DOF, 12-DOF dexterous hands, 3kg single-arm payload, 2hr battery. Pure vision (BEV+Transformer+OCC) with 6 RGB cameras.
  • N1 Open-source RobotOpen-source humanoid robot platform for research and development community.
  • ArmMotus / ExoMotus Rehabilitation RobotsUpper and lower limb rehabilitation robot series. CE MDR Class II certified. Deployed in medical institutions worldwide.
  • FSA Joints (Force-controlled Series Actuator)Self-developed force-controlled actuators powering GR series humanoid robots.

Key investors

  • IDG Capital (IDG资本)
  • SoftBank Vision Fund 2
  • Prosperity7 Ventures (Saudi Aramco)
  • Guoxin Investment
  • Pudong Venture Capital (浦东创投)
  • Zhangjiang Science & Technology
  • Junshan Capital (钧山资本)
  • Runyang Technology (润阳科技)
  • Yuanjing Capital

Milestones

  • 2015-07Founded by Gu Jie (顾捷), initially focused on rehabilitation robotics
  • 2022-01Series D led by SoftBank Vision Fund 2 (¥400M RMB)
  • 2023-07Launched GR-1 humanoid robot — first Chinese humanoid to achieve mass production
  • 2024-06Four rehabilitation robots pass EU CE MDR Class II certification
  • 2024-09Launched GR-2 with 53 DOF, 12-DOF dexterous hands, pure vision perception
  • 2025-01Completed ~¥800M Series E; valued at ¥8 billion, officially a unicorn
  • 2025-03Released open-source robot N1; NVIDIA trained humanoid models using GR-1 teleoperation
  • 2025-05Runyang Technology invests additional ¥300M

Competitive position

One of China's leading humanoid robot companies, differentiated by rehabilitation robotics heritage giving real-world medical deployment experience. GR-1 was among the first Chinese humanoids to ship. 2025 target: thousands of units total, including 300 bipedal humanoids. Valued at ¥8B (~$1.1B) — officially a unicorn. Dual business line (rehab + humanoid) provides revenue stability that pure humanoid startups lack. Founder's background at FANUC provides deep robotics industry knowledge.

Recent activity

No events tracked yet — this company is monitored daily.

Disclaimer

This profile is part of the China Physical AI Index — a public information product published by Tech Buzz China for informational and educational purposes only. It is not investment advice and is not a recommendation regarding Fourier Intelligence or any other security. Company data is based on public filings and TBC research; revenue-exposure estimates are point-in-time and subject to update. See the full methodology §11 and disclaimer page.